Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra viruses

利用多能干细胞生成人类动脉和静脉细胞,凸显了尼帕病毒和亨德拉病毒的动脉嗜性。

阅读:2
作者:Lay Teng Ang ,Alana T Nguyen ,Kevin J Liu ,Angela Chen ,Xiaochen Xiong ,Matthew Curtis ,Renata M Martin ,Brian C Raftry ,Chun Yi Ng ,Uwe Vogel ,Angelika Lander ,Benjamin J Lesch ,Jonas L Fowler ,Alyssa R Holman ,Timothy Chai ,Siva Vijayakumar ,Fabian P Suchy ,Toshinobu Nishimura ,Joydeep Bhadury ,Matthew H Porteus ,Hiromitsu Nakauchi ,Christine Cheung ,Steven C George ,Kristy Red-Horse ,Joseph B Prescott ,Kyle M Loh

Abstract

Stem cell research endeavors to generate specific subtypes of classically defined "cell types." Here, we generate >90% pure human artery or vein endothelial cells from pluripotent stem cells within 3-4 days. We specified artery cells by inhibiting vein-specifying signals and vice versa. These cells modeled viral infection of human vasculature by Nipah and Hendra viruses, which are extraordinarily deadly (∼57%-59% fatality rate) and require biosafety-level-4 containment. Generating pure populations of artery and vein cells highlighted that Nipah and Hendra viruses preferentially infected arteries; arteries expressed higher levels of their viral-entry receptor. Virally infected artery cells fused into syncytia containing up to 23 nuclei, which rapidly died. Despite infecting arteries and occupying ∼6%-17% of their transcriptome, Nipah and Hendra largely eluded innate immune detection, minimally eliciting interferon signaling. We thus efficiently generate artery and vein cells, introduce stem-cell-based toolkits for biosafety-level-4 virology, and explore the arterial tropism and cellular effects of Nipah and Hendra viruses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。